Neuropathic pain in patients with post-COVID-19

Basit Öğe Kaydı
dc.authoridAkturk, SEMRA/0000-0001-9960-6851
dc.authoridCOMRUK, EMINE BURCU/0000-0003-0940-2084
dc.authorwosidAkturk, SEMRA/KTH-9105-2024
dc.contributor.authorComruk, Emine Burcu
dc.contributor.authorBuyukavci, Raikan
dc.contributor.authorComruk, Erol
dc.contributor.authorAkturk, Semra
dc.contributor.authorErsoy, Yuksel
dc.date.accessioned2024-08-04T20:10:21Z
dc.date.available2024-08-04T20:10:21Z
dc.date.issued2023
dc.departmentİnönü Üniversitesien_US
dc.description.abstractOBJECTIVE: In this study, we aimed to determine the continuing pain during the post-COVID-19 period the frequency of neuropathic pain in these patients, and the factors affecting the frequency. METHODS: A total of 209 participants were included in the study who had COVID-19 disease (PCR-positive) aged 18-75 years. The demographic characteristics and COVID-19 severity data were recorded by questioning the patients. The musculoskeletal pain was also assessed using Visual Analog Scale (VAS) and the extended Nordic musculoskeletal system questionnaire (NMQ-E). In addition, the neuropathic components of pain were evaluated using the Leeds Assessment of neuropathic symptoms and Signs (LANSS) pain scale and the Pain-DETECT questionnaire (PDQ). RESULTS: The mean time elapsed since COVID-19 was 5.76 & PLUSMN;2.95 months (min, 1; max, 12). Six patients (2.9%) had neuropathic pain according to the LANSS score, and 12 patients (5.7%) according to the PDQ score. The NMQ-E indicated that the most pain was detected in the back (20.1%), low back (15.3%), and knee (11.5%) regions during the post-COVID-19 period. According to both neuropathic pain scales; low back pain (p=0.001/0.001) and knee pain (p=0.001/0.01) were more common in patients with PDQ/LANSS neuropathic pain. Logistic regression analysis showed that there were significant associations between neuropathic pain and acute COVID-19 VAS score. CONCLUSION: This study demonstrated that musculoskeletal pain was prominent mostly in the back, low back, and knee during the post-COVID-19 period. The incidence of neuropathic pain was 2.9%-5.7% depending on the evaluation parameters. Neuropathic pain is a finding that should be considered during the post-COVID-19 period.en_US
dc.identifier.doi10.14744/nci.2022.31932
dc.identifier.endpage366en_US
dc.identifier.issn2148-4902
dc.identifier.issn2536-4553
dc.identifier.issue3en_US
dc.identifier.pmid37435282en_US
dc.identifier.scopus2-s2.0-85164724952en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage359en_US
dc.identifier.trdizinid1189865en_US
dc.identifier.urihttps://doi.org/10.14744/nci.2022.31932
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1189865
dc.identifier.urihttps://hdl.handle.net/11616/92735
dc.identifier.volume10en_US
dc.identifier.wosWOS:001041293500012en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherKare Publen_US
dc.relation.ispartofNorthern Clinics of Istanbulen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCOVID-19en_US
dc.subjectpainen_US
dc.subjectpost-COVID-19en_US
dc.subjectneuropathic painen_US
dc.titleNeuropathic pain in patients with post-COVID-19en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu